Pussinen Cynthia
Chief Executive Officer
Award
Calculated transaction value
$0
1,000,000 shares @ $0
Traded
Nov 2, 2026
Filed
Nov 4, 2026
You're reading the free version. Trader adds the live tape and alerts.
Start tracking
Estrella Immunopharma, Inc.
ESLA
Transactions reported in official disclosures
5 trades
| Reporting person | Filed | Transaction | Transaction value | Source | Actions |
|---|---|---|---|---|---|
| Pussinen Cynthia Chief Executive Officer | Nov 4, 2026 2-day lag | Award Nov 2, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Liu Cheng CEO | Aug 26, 2026 1-day lag | Exercise Aug 25, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Liu Cheng CEO | Aug 26, 2026 1-day lag | Exercise Aug 25, 2026 | $81.5K Filed shares x price | SEC Form 4 View filing | |
| Xu Jiandong Chief Financial Officer | Aug 25, 2026 7-day lag | Exercise Aug 18, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Xu Jiandong Chief Financial Officer | Aug 25, 2026 7-day lag | Exercise Aug 18, 2026 | $81.5K Filed shares x price | SEC Form 4 View filing |
Liu Cheng
CEO
Exercise
Calculated transaction value
$0
100,000 shares @ $0
Traded
Aug 25, 2026
Filed
Aug 26, 2026
Liu Cheng
CEO
Exercise
Calculated transaction value
$81.5K
100,000 shares @ $0.81
Traded
Aug 25, 2026
Filed
Aug 26, 2026
Xu Jiandong
Chief Financial Officer
Exercise
Reported value range
Not reported
100,000 shares
Traded
Aug 18, 2026
Filed
Aug 25, 2026
Xu Jiandong
Chief Financial Officer
Exercise
Calculated transaction value
$81.5K
100,000 shares @ $0.81
Traded
Aug 18, 2026
Filed
Aug 25, 2026